4.6 Article

The 3A3B score: The simple risk score for heart failure with preserved ejection fraction - A report from the CHART-2 Study

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 284, Issue -, Pages 42-49

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2018.10.076

Keywords

Heart failure; Left ventricular ejection fraction; HFpEF; Prognosis; Risk score

Funding

  1. Japanese Ministry of Health, Labour andWelfare
  2. Japanese Ministry of Education, Culture, Sports, Science and Technology
  3. Japan Agency for Medical Research and Development, Tokyo, Japan [15ek0210043h0001, 16ek0210056h0001, 16ek0210043h0002]
  4. National Heart, Lung, and Blood Institute, National Institutes of Health [HHSN268200425207C]
  5. National Medical Research Council of Singapore
  6. Agency for Science, Technology and Research Biomedical Research Council Asian Network for Translational Research and Cardiovascular Trials program
  7. Boston Scientific Investigator Sponsored Research Program
  8. Bayer

Ask authors/readers for more resources

Background: Few simple risk models, without echocardiography have been developed for patients with heart failure (HF) and preserved left ventricular ejection fraction (LVEF) (HFpEF). Methods: To develop a risk score to predict all-cause death for HFpEF patients, we examined 1277 HF patients with LVEF >= 50% and BNP >= 100 pg/ml in the CHART-2 Study, a large-scale prospective cohort study for HF in Japan. We selected the optimal subset of covariates for the score with Cox proportional hazard models and random survival forests (RSF). Results: During the median 5.7-year follow-up, 576 deaths occurred. Cox models and RSF analyses consistently indicated age >= 75 years, albumin <3.7 g/dl, anemia, BMI <22 kg/m(2), BNP >= 300 pg/ml (or NT-proBNP >= 1400 pg/ml), and BUN >= 25 mg/dl, as the important 6 prognostic variables. Incorporating these 6 variables, we developed a scoring system (3A3B score, with 2 points given to age >= 75 years and 1 point to the others based on the hazard ratios. The discrimination ability of the risk score was excellent (c-index 0.708). Regarding model goodness-of-fit, the overall gradient in 5-year risk was well captured by the score. The predictive accuracy of the 3A3B score was confirmed in the external validation cohorts from the TOPCAT trial (N=835, c-index 0.652) and the ASIAN-HF registry (N=170, c-index 0.741). Conclusions: We developed a simple risk score to predict long-term prognosis of HFpEF patients. The 3A3B score, comprising 6 commonly available parameters in daily practice, has potential utility in the risk stratification and management of HFpEF patients. (c) 2018 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available